The measurement of body mass index and waist circumference: An informative and cheep tool in preventive cardiology;La mesure du poids et du tour de taille: Une précieuse source simple et peu coûteuse d'informations pour la prévention cardiovasculaire

Medecine et Hygiene

Volumn 62, Issue 2470, 2004, Pages 399-405

  Darioli, Roger ^a   Perdrix, Jean ^a   Masson, Jean Christophe ^b   Giusti, Vittorio ^a   Prior, John ^c  

^a POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

^b Lig de la Sante du Canton de Vaud   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; BODY MASS; CARDIOLOGY; CARDIOVASCULAR DISEASE; CORRELATION ANALYSIS; FEMALE; HEART PROTECTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLIC SYNDROME X; OBESITY; REVIEW; RISK FACTOR;

EID: 1442303989     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
2. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 7: 539-53.
3. WHO Information. Communiqué de presse 0MS/46. L'é pidémie d'obésité expose des millions de personnes à d'autres maladies. http://www.who.int/archives/inf-pr-1997/fr/cp97-46.html.
4. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 2001; 285: 2486-97.
5. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: Third joint task force of european and other societies on cardiovascular disease prevention in clinical practice. Eur Heart J 2003; 24: 1601-10.
6. International task force for prevention of coronary heart disease. Pocket guide to prevention of coronary heart disease. http://www. agla.ch/users/guidelines.pdf.
7. Darioli R, Mooser V, Perdrix J, et al. Répercussions de la sédentarité sur le profil des facteurs de risque cardiovasculaire et le risque d'accident coronarien chez les employés d'entreprise du canton de Vaud. Med Hyg 2002; 60: 567-72.
8. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97: 1837-47.
9. Isomaa B, Almgreen P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
10. Adlerberth AM, Rosengren A Wilhelmsen L, et al. Diabetes and long-term risk of mortality from coronary heart disease and other causes in middle-aged Swedish men. Diabetes Care 1998; 21: 53945.
11. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-16.
12. Jenkins AJ, Lyons TJ, Zhenc D, et al. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort. Diabetes Care 2003; 26: 810-8.
13. Schutz Y, Woringer V. Obesity in Switzerland: A critical assessment of prevalence in children and adults. Int J Ob 2002; 26 (Suppl. 2): S2-S11.
14. Wietlisbach V, Paccaud F, Rickenbach M, et al. Trends in Risk factors (1984-1993) in a Swiss region: Results of three population surveys. Prev Med 1997; 26: 523-33.
15. Prior J, van Melle G, Darioli R, et al. Evaluation of a multi-component worksite health promotion program for cardiovascular risk. Soumis pour publication, 2003.
16. Hense HW, Schulte H, Löwel H. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and PROCAM cohorts. Eur Heart J 2003; 24: 937-45.